Health Tech Marketing: The Measurement Gap Between Activity and Revenue

Most health tech marketing teams measure what is easy and report it with confidence: impressions, downloads, engagement rate, follower growth. The metrics deciding whether the function survives a budget review, pipeline created and revenue closed, go largely untracked. The gap between activity and revenue is the defining measurement problem in the category, and a long sales cycle widens it by placing the revenue so far downstream teams optimize the nearest proxy and drift from the outcome deciding their fate.
The pattern is not confined to health technology, which is part of why it persists unexamined. It is an industry-wide habit the structure of health system selling amplifies into a genuine risk, because the longer the cycle, the more tempting the proxy and the harder the honest number is to produce.
This piece looks at why health tech marketing measures activity while revenue goes untracked, what to measure instead, and how attribution works across a long cycle. It draws on Demand Gen Report benchmarks on measurement and attribution, Gartner research on B2B go-to-market, and McKinsey research on commercial capabilities.
Key Takeaways
- The gap is between activity and revenue. Engagement is widely tracked; pipeline and formal ROI rarely are.
- A long cycle makes the proxy tempting. With revenue quarters away, teams optimize the metric present today and drift from pipeline.
- Measure the chain to revenue. Pipeline created, conversion by source, and cost per qualified opportunity replace impressions.
- Leading indicators forecast a long cycle. Account progression, multi-threaded engagement, and reference requests precede revenue reliably.
- Production without promotion wastes the spend. Assets built and underdistributed spend the full cost while starving the return.
What the Data Shows About Marketing Measurement
Across marketing, engagement is the metric teams capture and revenue is the metric they do not. Most marketers track impressions, downloads, and engagement rate. Far fewer track lead generation, and fewer still track direct revenue attribution or formal return on investment. The minority connecting the work to a financial outcome is small, and in health technology the long cycle makes the shortfall worse.
A related pattern compounds it. Many organizations spend more on producing content than on distributing it, so well-made assets go unseen. The two habits reinforce each other: teams build what they cannot connect to revenue and underdistribute what they build.
The principle is old and mostly ignored. Downloads are vanity; contacts and contracts are sanity. In health technology marketing, the vanity numbers are always available and the sanity numbers take work to produce.
Why the Long Cycle Makes Activity Metrics More Seductive
When a sale closes in weeks, the distance between marketing activity and revenue is short enough to see and attribute. When a sale closes in twelve to twenty-four months, revenue sits so far downstream an engagement metric available today becomes an irresistible substitute. The team optimizes the proxy because the proxy is present and the revenue is not, and over several quarters the program drifts toward whatever moves the proxy rather than whatever moves pipeline.
The drift is invisible until a budget review asks what the marketing spend produced in pipeline and the answer arrives in impressions. At the point the function is defending activity to an audience funding outcomes, the engagement dashboard looking healthy all year becomes the evidence against it. Measurement chosen for convenience early becomes a liability late.
Reporting activity when the board wants pipeline?
Outcomes Rocket connects marketing measurement to revenue across a long cycle.
→ Talk to a Healthtech Marketing Expert
What Health Tech Marketing Should Measure Instead
Closing the gap means measuring the chain from activity to revenue, accepting attribution in a long cycle is imperfect and still directionally decisive.
- Pipeline created and pipeline influenced, valued in dollars and segmented by source.
- Opportunity conversion rate by source, exposing which programs produce pipeline closing rather than pipeline merely opening.
- Cost per qualified opportunity, the honest efficiency measure cost per lead disguises.
- Budget-qualified versus engagement-qualified volume, separating interest from proximity to a purchase.
- Reference velocity and sales cycle length by segment, the leading indicators predicting revenue before revenue arrives.
Distinguishing budget-qualified from engagement-qualified demand is the pivot, and it depends on a scoring model built for it, the province of lead scoring.
Leading Indicators Predicting Revenue in a Long Cycle
A twelve-to-twenty-four-month cycle does not force a team to fly blind for two years. Certain signals predict eventual revenue early enough to steer. Movement of named target accounts into and through pipeline stages, multi-threaded engagement across a buying committee rather than a single contact, security and integration documentation accessed by a target account, and reference calls requested all precede revenue reliably enough to serve as a forecast.
Building the pipeline discipline behind these signals, the work of moving portfolio to pipeline, lets a marketing leader report progress in a cycle where closed revenue is quarters away.
The Production-Over-Promotion Trap
Underdistribution is a specific and avoidable waste: assets built to a high standard and then left to sit. A report nobody amplifies, a podcast episode nobody promotes, a webinar nobody repurposes. The production cost is fully spent, and the return depends entirely on the promotion the budget shortchanged.
The correction is to treat distribution as a first-class line rather than a remainder, and to design every asset for reuse from the start. HLTH turned a single podcast operation into a sponsor retention engine by doing exactly this, backed by disciplined audio production for healthcare.
Reporting Marketing to a Board Funding Outcomes
A board evaluates marketing the way it evaluates any function competing for capital: on what the spend returns. An activity report invites the wrong question, why the company pays for impressions, while a pipeline report invites the right one, how to fund more of what produces revenue. The shift is as much about the format of the conversation as the underlying data. A marketing leader who opens with qualified pipeline created, conversion by source, and cost per opportunity is speaking the board's language, and a leader who opens with reach and engagement is speaking a language the board has learned to distrust. The numbers determine the funding, and the framing determines whether the numbers get heard.
Bill Moschella, co-founder of Evariant, relayed what health system marketing leaders told him once their work connected to growth: “I’m not just controlling the brand, I’m contributing to growth and to the longevity of this business and organization.”
Attribution Without Certainty
Perfect attribution does not exist in a multi-touch, multi-stakeholder, multi-quarter health system sale, and waiting for it is an excuse to measure nothing. Workable practice combines several imperfect signals: multi-touch models crediting the full journey, account-level rather than lead-level analysis, and a self-reported source captured at the point of sales contact, which frequently reveals influence no tracking system recorded. Together they support a defensible narrative connecting marketing to revenue, the standard a board applies.
The perfectionist objection, if attribution is imperfect it is worthless, serves the status quo. A directional read connecting programs to pipeline beats a precise count of impressions every time, because the board funds the function on the former and ignores the latter. Good enough and honest outperforms exact and irrelevant.
What Changes When Revenue Becomes the Measure
The dashboard stops leading with impressions and starts leading with pipeline. Distribution earns a real budget line. Programs are judged on the opportunities they create and close rather than the engagement they generate. The marketing leader walks into the budget review with a revenue narrative instead of an activity report, and the function is funded on what it produces rather than defended on what it did. Contacts and contracts replace downloads.
Frequently Asked Questions
Why does health tech marketing measure activity instead of revenue?
Engagement metrics are easy to capture and always available, while revenue in a twelve-to-twenty-four-month cycle sits far downstream. Most marketers track engagement and only a minority track formal return on investment, a gap the long health technology sales cycle widens by making the nearest proxy the most tempting measure.
What marketing metrics should a healthtech CMO report to the board?
Pipeline created and influenced in dollars, opportunity conversion by source, cost per qualified opportunity, budget-qualified versus engagement-qualified volume, and reference velocity. These connect the work to revenue and let a board fund the function on outcomes rather than activity.
How do you attribute revenue in a long sales cycle?
Combine imperfect signals: multi-touch models crediting the full journey, account-level analysis rather than lead-level, and a self-reported source captured at sales contact. Perfect attribution is impossible in a multi-stakeholder health system sale, but a defensible narrative connecting marketing to revenue is achievable and sufficient.
What is the production-over-promotion trap?
Many organizations spend more on producing content than on promoting it, and some direct the large majority of budget to production alone. The result is high-quality assets going underdistributed, spending the full production cost while starving the promotion deciding the return.
How do you measure marketing ROI in health technology?
Track leading indicators predicting revenue early, named-account pipeline progression, multi-threaded committee engagement, documentation access by target accounts, and reference requests, then connect them to closed revenue through account-level attribution. This produces a return measure holding even when closed revenue is several quarters away.
Ready to measure marketing on revenue rather than activity?
Outcomes Rocket installs the pipeline metrics, attribution, and leading indicators a board recognizes.
FAQs
Sources
- Demand Gen Report - 2025 ABM Benchmark Survey - Research on account-based ROI, attribution, and measurement challenges. https://www.demandgenreport.com/resources/2025-account-based-marketing-benchmark-survey/50610/
- Gartner - Buying Group Consensus Survey (2025) - Research on B2B buying-team dynamics and go-to-market decision-making. https://www.gartner.com/en/newsroom/press-releases/2025-05-07-gartner-sales-survey-finds-74-percent-of-b2b-buyer-teams-demonstrate-unhealthy-conflict-during-the-decision-process
- McKinsey - Commercial Capabilities: A Predictor of Growth for Medtech - Research linking integrated commercial execution and measurement to growth. https://www.mckinsey.com/industries/life-sciences/our-insights/commercial-capabilities-a-predictor-of-growth-for-medtech-companies
Turn Healthcare
Insight
into Accelerated Growth
Our healthcare growth teams works closely with you to design strategies tailored to your unique goals and market dynamics, fully focused on growth.